Related Experiment Video
Updated: Sep 11, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
hsa_circ_0004276 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells and exacerbates
BaiQuan Fu1, YuXin Sui1, Yu Liu1
1Department of Orthopaedics, Chifeng Municipal Hospital, Chifeng City, Inner Mongolia Autonomous Region, China.
Insights
Circular RNA hsa_circ_0004276 is highly expressed in postmenopausal osteoporosis (PMO) and interacts with ELAVL1 to regulate bone cell differentiation. This study highlights hsa_circ_0004276 as a potential diagnostic marker and therapeutic target for PMO.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Postmenopausal Osteoporosis (PMO) is a significant health concern.
- Identifying reliable diagnostic markers and understanding molecular mechanisms are crucial for PMO management.
Purpose of the Study:
- To investigate hsa_circ_0004276 as a diagnostic marker for PMO.
- To explore the interaction between hsa_circ_0004276 and ELAVL1 in PMO pathogenesis.
Main Methods:
- Differential expression analysis of circRNAs in PMO patients.
- Validation of hsa_circ_0004276 structure and expression.
- Assessment of hsa_circ_0004276 and ELAVL1 in serum samples.
- In vitro studies on Bone Marrow Mesenchymal Stem Cells (BMSCs) osteogenic differentiation.
Main Results:
- hsa_circ_0004276 was upregulated in PMO patients and correlated with lower bone mineral density.
- hsa_circ_0004276 demonstrated high diagnostic accuracy for PMO.
- hsa_circ_0004276 interacted with ELAVL1, affecting BMSC osteogenic differentiation.
- ELAVL1 expression was reduced in PMO patients and positively correlated with hsa_circ_0004276.
Conclusions:
- hsa_circ_0004276 regulates BMSC osteogenic differentiation via ELAVL1 interaction in PMO.
- This study offers insights into PMO molecular mechanisms.
- hsa_circ_0004276 presents a potential therapeutic target for PMO.
Objective:
The aim of this study was to investigate the potential of hsa_circ_0004276 as a diagnostic marker for Postmenopausal Osteoporosis (PMO) and its potential interaction with the RNA-binding protein ELAV-like RNA binding protein-1 (ELAVL1).
Methods:
The circRNA expression profiles obtained from the GSE159121 dataset were used to screen for differentially expressed circRNAs in patients with PMO. hsa_circ_0004276 was further analyzed and validated for its circular structure using a bioinformatics website, actinomycin D, and RNase R assays. Serum samples from 115 PMO patients and 103 healthy controls were collected. RT-qPCR and western blot were applied to assess hsa_circ_0004276 and ELAVL1. The effects of hsa_circ_0004276 and ELAVL1 on osteogenic differentiation of human Bone Marrow Mesenchymal Stem Cells (BMSCs) were investigated by in vitro experiments.
Results:
hsa_circ_0004276 was highly expressed in PMO patients and negatively correlated with low bone mineral density. hsa_circ_0004276 had high specificity and sensitivity for the diagnosis of PMO. hsa_circ_0004276 significantly interacted with ELAVL1. During BMSC osteogenic differentiation, hsa_circ_0004276 knockdown significantly increased calcium deposition and ALP activity, while hsa_circ_0004276 overexpression showed the opposite effect. In addition, ELAVL1 expression was reduced in PMO patients and positively correlated with hsa_circ_0004276.
Conclusion:
hsa_circ_0004276 regulates osteogenic differentiation of BMSCs through its interaction with ELAVL1 in PMO pathogenesis. This finding provides a new perspective for the study of the molecular mechanism of PMO and a theoretical basis for the development of new therapeutic targets.
More Related Videos
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Regulation of Hematopoietic Stem Cells
Mesenchymal Stem Cells